COMMUNIQUÉS West-GlobeNewswire

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

04/03/2024 - 22:05

Q4 2023 revenue $26.5 million and FY 2023 revenue $96.6 million Guiding FY 2024 revenue range $114.0-118.0 million and operating cash flow breakeven by YE 2024 MARLBOROUGH, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- [...]

Stereotaxis Reports 2023 Full Year Financial Results

04/03/2024 - 22:05

ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth [...]

Health Catalyst to Participate in Upcoming Investor Conferences

04/03/2024 - 22:05

SALT LAKE CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced [...]

Apogee to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases on March 5, 2024

04/03/2024 - 22:01

SAN FRANCISCO and WALTHAM, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc . (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic [...]

Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

04/03/2024 - 22:01

–Announced prioritization of clinical programs to focus on late-stage development of oral difelikefalin for notalgia paresthetica (NP)– –Completed enrollment of KOURAGE 1 Part A portion of NP pivotal program ahead of [...]

Cytokinetics to Participate in March Investor Conferences

04/03/2024 - 22:00

SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor conferences in March: [...]

Arcutis Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

04/03/2024 - 22:00

WESTLAKE VILLAGE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]

Avadel Pharmaceuticals Issues Statement On Patent Litigation

04/03/2024 - 21:37

DUBLIN, Ireland, March 04, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), today issued a statement in response to a jury ruling from the United States District Court for the District of Delaware (“ [...]

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to April 3, 2024

04/03/2024 - 20:25

MIAMI, March 04, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”), a special purpose acquisition company, announced today that on March 1, 2024, its sponsor, [...]

Better Choice to Explore Non-Equity Related Capital Solutions to Fund the R&D of its Domestic Animal Targeted GLP1 Supplement

04/03/2024 - 20:00

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced that after successfully completing the acquisition [...]

Sporttrade and Birches Health Partner to Launch Responsible Gaming Education and Problem Gambling Resources

04/03/2024 - 19:51

ATLANTIC CITY, N.J., March 04, 2024 (GLOBE NEWSWIRE) -- Birches Health and Sporttrade are pleased to kick off Problem Gambling Awareness month (March) by announcing a partnership. This initiative focuses on increasing [...]

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

04/03/2024 - 19:10

Company Announcement COPENHAGEN, Denmark; March 4, 2024 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]

MannKind Corporation Announces Participation at Upcoming Conferences

04/03/2024 - 19:01

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., March 04, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products and [...]

Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas

04/03/2024 - 19:00

Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital [...]

InnovAge Launches First PACE Center in Florida Providing Comprehensive Healthcare Program for Seniors to Promote Independence

04/03/2024 - 18:50

TAMPA, Fla., March 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All- [...]

Resolutions from the Extraordinary Shareholders’ Meeting 2024

04/03/2024 - 17:06

Company Announcement no. 10 March 4, 2024 Today an extraordinary shareholders’ meeting was conducted. The following resolutions were made : Adoption of Novonesis A/S as secondary name and amendment of the Articles of [...]

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

04/03/2024 - 16:00

ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following [...]

Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024

04/03/2024 - 16:00

Researchers present abstracts and poster sessions showcasing research and clinical solutions Joint session planned with Illumina HOUSTON, March 04, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical diagnostic [...]

ACTG Presents Study at CROI Elucidating Mechanism of CMV on Aging-Related Pathways in HIV

04/03/2024 - 16:00

LOS ANGELES, March 04, 2024 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented the poster “Suppressing Asymptomatic CMV with Letermovir Reshapes [...]